Skip to content

Clinical trials

Terminated Phase 3 Lymphoma, Large B-Cell, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 3 Status: Terminated Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20062
20112
20121
20151
20161
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lymphoma Study Association3
Hoffmann-La Roche2
Pfizer2
Spectrum Pharmaceuticals, Inc2
Baxalta now part of Shire1
City of Hope Medical Center1
JHL Biotech, Inc.1
Martin, Paul1
OHSU Knight Cancer Institute1
SWOG Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse15
Lymphoma6
Lymphoma, Non-Hodgkin5
Burkitt Lymphoma4
Lymphoma, Follicular4
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Chronic-Phase3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Large-Cell, Immunoblastic3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.